Energy Transfer's predictable cash flow from long-term contracts and distribution growth makes it attractive for income ...
(CSIQ) on Tuesday reported fourth-quarter profit of $33.9 million. On a per-share basis, the Ontario, Ontario-based company said ...
X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...
Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...